VideoWelcome: Judith Hasko (Video)Meet Judith Hasko who joined WilmerHale in 2024 as a partner in our Palo Alto office and co-chair of the firm's Life Sciences practice.United StatesFood, Drugs, Healthcare, Life SciencesWilmerHale
ArticleWhite House Releases More Details On President's Precision Medicine InitiativePresident Obama has revealed more details about the Precision Medicine Initiative, an interagency project aimed at revolutionizing the way health care professionals treat certain diseases. United StatesFood, Drugs, Healthcare, Life SciencesJones Day
ArticleWhy Study The Draft 2014 National Nanotech Initiative Strategic Plan?The NNI has just released its 2014 draft Strategic Plan for public comment. United StatesFood, Drugs, Healthcare, Life SciencesFoley & Lardner LLP
VideoWill Privacy Laws Adapt? (Video)Jami Vibbert discusses the current application of privacy laws to healthcare and life sciences companies. Efforts to enforce those laws will show that they weren't ...United StatesFood, Drugs, Healthcare, Life SciencesArnold & Porter
ArticleBio/Pharma NewsletterThe November issue of Squire Patton Boggs Bio/Pharma Beat is now available. Our monthly newsletter reports on important patent law developments in biotech,...United StatesIntellectual PropertySquire Patton Boggs LLP
ArticleCelltrion Confirms Bioequivalence For CT-P39 Against Xolair In Interim Results Of Phase 3 StudyOn April 10, 2023, Celltrion confirmed the bioequivalence of CT-P39 to treat allergic asthma and chronic urticaria, through its interim results from its global phase 3 clinical trials at 24 weeks.United StatesIntellectual PropertyGoodwin Procter LLP
ArticleDeal On IP Rights For Biologic Drugs Under TPP CloseAccording to industry and congressional sources, a deal on intellectual property rights for biologic drugs under the TPP may be in the near future. United StatesIntellectual PropertyJones Day
ArticleGenentech And Dr. Reddy's Settle BPCIA Rituximab LitigationGenentech, Hoffmann-La Roche, and Biogen have settled their BPCIA litigation against Dr. Reddy's Laboratories ("DRL") and Fresenius Kabi. United StatesIntellectual PropertyGoodwin Procter LLP
VideoIntellectual Property Partner Jason Murata In Conversation With The Hsu Untied Podcast (Video)Jason Murata joins Richard Hsu on the Hsu Untied podcast to discuss his background in biochemistry and biotechnology...United StatesIntellectual PropertyAxinn LLP
ArticleJudge Sleet Concludes That Defendants Did Not Prove Invalidity Of Asserted Claim In ANDA ActionThe Court issued its findings of fact and conclusions of law pursuant to Federal Rule of Civil Procedure 52(a).United StatesIntellectual PropertyFox Rothschild LLP
ArticleLife Sciences Patent Trends In 2022 – Doctrine Of EquivalentsThe Federal Circuit continues to tighten the standards for written description of functional claims, particularly in the biologics realm...United StatesIntellectual PropertyMorrison Foerster
ArticlePodcast: Arthrex v. Smith & NephewIn this episode of the DeviceTalks Weekly podcast, Mike Jakes discusses why the medical device industry should be watching when the...United StatesIntellectual PropertyFinnegan, Henderson, Farabow, Garrett & Dunner LLP
ArticleSCOTUS Case With Implications For Attorney-Client Privilege Between CIPOs And C-SuiteThe article examines how the U.S. Supreme Court may broaden confidentiality of communications containing dual-purpose legal and business advice.United StatesIntellectual PropertyHerbert Smith Freehills Kramer LLP
ArticleVanda Strikes Out At The Supreme CourtTwo weeks ago we discussed Vanda Pharmaceuticals' ambitious cert petition asking the Supreme Court to discontinue the "reasonable expectation of success" standard for patent...United StatesIntellectual PropertyAxinn LLP
ArticleWhat High Court Will Consider In Helsinn On-Sale Bar CaseThe US Supreme Court may soon resolve an issue that has sparked much debate since the enactment of the Leahy-Smith America Invents Act—namely, whether under the AIA, an inventor's sale of an invention to a third party ...United StatesIntellectual PropertyWilmerHale
ArticleBIS And DDTC Revise Controls On Export Of Toxicological Agents And Directed Energy WeaponsOn July 28, 2016, the Department of Commerce's Bureau of Industry and Security (BIS) and the Department of State's Directorate of Defense Trade Controls issued final rules implementing revisions to U.S...United StatesInternational LawBakerHostetler
ArticleU.S. Customs And Border Protection Authorized To Detain Certain Exports Of Health And Medical Materials Pursuant To FEMA Temporary RuleBeginning April 7, 2020, CBP is authorized to temporarily detain all shipments of five categories of personal protective equipment used in the response to and treatment of COVID-19, pursuant to a Temporary Rule issued by FEMA.United StatesInternational LawAkin
ArticleParties In Amgen v. Hospira Pegfilgrastim Litigation Stipulate To Dismissal Of All ClaimsOn March 19, 2022, the parties in the Amgen Inc. v. Hospira Inc. (D. Del., No. 20-201) NEULASTA®/pegfilgrastim litigation submitted a stipulation to dismiss all claims and counterclaims...United StatesLitigation, Mediation & ArbitrationGoodwin Procter LLP
ArticleThe Biomaterials Access Assurance Act: An Underused Tool Against Forum ShoppingThe Biomaterials Access Assurance Act was enacted in 1998 to protect biomaterial suppliers of implanted medical devices from the expenses of defending baseless civil suits.United StatesLitigation, Mediation & ArbitrationPatterson Belknap Webb & Tyler LLP
PodcastAD Nauseam: Left To Our Own Devices (Podcast)In this episode, hosts Amy Mudge and Daniel Kaufman discuss various health-related cases involving medical devices and FTC rulings. They delve into notable cases such as the QRay bracelet, which claimed pain relief through ionization, and the ViaTek mosquito shield band, which purported to repel mosquitoes.United StatesMedia, Telecoms, IT, EntertainmentBakerHostetler